Fine Organic: HDFC Securities is bullish on this chemicals company, noting key strengths and giving it an upside of 22%+ on a share price of Rs. 3480. Analysts Nilesh Ghuge and team write that the recommendation is based on, "(1) constant focus on R&D, (2) diversified product portfolio, (3) capacity-led expansion growth opportunity, and (4) leadership in oleo-chemical based additives in the domestic and global markets with a loyal customer base." Their projection includes double digit profit growth. 

Cadila Healthcare: The outlook is strong for this healthcare company, according to Geojit, driven by domestic formulations. Analyst Sheen G assigns the company a target price of Rs. 632, an upside of 16%. "We expect growth momentum to continue," he notes, "backed by new launches in injectables and generic products, R&D investment, strengthening of development pipeline (417 ANDAs, 325 approvals), and rapid capacity enhancement." 

NMDC: ICICI Securities is bullish on this iron ore mining business, assigning it a target price of Rs. 210 - an upside of 39%. "PAT for the quarter was at Rs 3193 crore (up 499% YoY & 13% QoQ), higher than our estimate of 2704 crore," analyst Dewang Sanghavi writes, "NMDC has chalked out a capex plan of Rs 3750 crore for FY22E. Of this approx Rs 2150 crore would be spent on its upcoming steel plant."

KIMS: This hospital chain gets an upside of 18.8% from Edelweiss on a target of Rs. 1535. Analysts Praveen Sahay and Ajit Sahu note that "KIMS should continue benefiting from its regional market leadership, strong cash flow generation and focus on operational efficiency and capacity expansion." KIMS is planning to add 1,500 beds over the next four years at an approximate cost of INR90-110lakhs/bed - per bed capex slightly higher than historical rate.

HDFC Bank: RBI lifting the restriction on new credit card issue for the bank triggered a sigh of relief from investors, as well as a buy call from MOswal with a target price of 1800, an upside of 18.8%. "The RBI’s move addresses the key overhang as HDFC Bank is the largest credit card issuer in the country, and this segment is key to the bank’s overall profitability," analysts Nitin Aggarwal and team write. "The bank has lost ~0.6m cards since the embargo. On the other hand, ICICI Bank, SBI Card and Axis Bank added almost 1.3 mn, 0.75 mn and 0.3 mn new credit cards respectively over that period."